Literature DB >> 22783785

Community acquired pneumonia: assessment and treatment.

Caroline M Patterson1, Michael R Loebinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22783785      PMCID： PMC4953496          DOI： 10.7861/clinmedicine.12-3-283

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  20 in total

Review 1.  Resolution of pleural effusions.

Authors:  M Cohen; S A Sahn
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

2.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

3.  Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome.

Authors:  Rosario Menéndez; Antoni Torres; Rafael Zalacaín; Javier Aspa; Juan J Martín-Villasclaras; Luis Borderías; José M Benítez-Moya; Juan Ruiz-Manzano; Felipe Rodríguez de Castro; José Blanquer; Diego Pérez; Carmen Puzo; Fernando Sánchez-Gascón; José Gallardo; Carlos Alvarez; Luis Molinos
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

4.  Incidence and characteristics of viral community-acquired pneumonia in adults.

Authors:  L C Jennings; T P Anderson; K A Beynon; A Chua; R T R Laing; A M Werno; S A Young; S T Chambers; D R Murdoch
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

5.  Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia.

Authors:  Anke H W Bruns; Jan Jelrik Oosterheert; Mathias Prokop; Jan-Willem J Lammers; Eelko Hak; Andy I M Hoepelman
Journal:  Clin Infect Dis       Date:  2007-09-12       Impact factor: 9.079

6.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.

Authors:  T J Marrie; C Y Lau; S L Wheeler; C J Wong; M K Vandervoort; B G Feagan
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

7.  Thoracic empyema in patients with community-acquired pneumonia.

Authors:  Rabia A Ahmed; Thomas J Marrie; Jane Q Huang
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

8.  Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia.

Authors:  Jennie Johnstone; Thomas J Marrie; Dean T Eurich; Sumit R Majumdar
Journal:  Arch Intern Med       Date:  2007-10-08

Review 9.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

10.  Increasing hospital admissions for pneumonia, England.

Authors:  Caroline L Trotter; James M Stuart; Robert George; Elizabeth Miller
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883
View more
  4 in total

1.  Effect of daily manual toothbrushing with 0.2% chlorhexidine gel on pneumonia-associated pathogens in adults living with profound neuro-disability.

Authors:  Ria Prasad; Blanaid Daly; Graham Manley
Journal:  Access Microbiol       Date:  2019-10-21

2.  Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.

Authors:  Bassam Mahboub; Ashraf Al Zaabi; Ola Mohamed Al Ali; Raees Ahmed; Michael S Niederman; Rania El-Bishbishi
Journal:  BMC Pulm Med       Date:  2015-09-30       Impact factor: 3.317

Review 3.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

4.  Prognostic factors of severe community-acquired staphylococcal pneumonia in France.

Authors:  Yves Gillet; Anne Tristan; Jean-Philippe Rasigade; Mitra Saadatian-Elahi; Coralie Bouchiat; Michele Bes; Oana Dumitrescu; Marie Leloire; Céline Dupieux; Frédéric Laurent; Gérard Lina; Jerome Etienne; Philippe Vanhems; Laurent Argaud; Francois Vandenesch
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 16.671
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.